Posted on February 28th, 2010
the 15-year clinical study with Copaxone(R) (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis . . .
80 percent of patients were still walking without assistance despite a mean MS disease duration of 22 years, and two-thirds of patients have not transitioned to secondary progressive MS read more »
Categories: Copaxone, MS, Research, Therapies Tags: Copaxone, MS, multiple sclerosis, relapsin remitting multiple sclerosis, Symptoms, therapy, treatment
Posted on November 29th, 2009
The following questions ask for your views about the impact of MS on your day-to-day life during the past two weeks read more »
Categories: MS Tags: difficulty doing things, limitations in activities, MS Impact Scale, physically demanding tasks, tremor
Posted on May 31st, 2009
Fish Really Is ‘Brain Food’:
ScienceDaily (May 22, 2009) —
Eating fish – long considered ‘brain food’ – may really be good for the old gray matter, as is a healthy dose of sunshine, new research suggests.
University of Manchester scientists in collaboration with colleagues from other European centers have shown that higher levels of vitamin D – primarily synthesized in the skin following sun exposure but also found in certain
Categories: Cognitive Ability
Posted on March 31st, 2009
Helen Yates, Chief Executive of the Multiple Sclerosis Resource Centre (MSRC) said: “We truly hope that the research leads to a treatment for this very worrying and potentially life threatening condition. It is important that people affected by MS that are
Categories: MS Tags: therapy
Posted on March 30th, 2009
Biogen Idec, Elan’s partner in the development and sale of Tysabri, is testing the efficacy of a malaria pill developed during the Vietnam war in treating progressive multifocal leukoencephalopathy (PML), the brain infection read more »
Categories: Tysabri Tags: immune-modulating drugsAdd new tag, MS, multiple sclerosis, PML, tysabri
Posted on March 30th, 2009
Multiple sclerosis (MS) in children is being recognized with increasing frequency. The first descriptions of MS in children were published by Charcot between 1829 and 1849, though it was not for another 50 years that MS in children was again described in the literature (Hanefeld, 2007). There are now several national programs focused read more »
Categories: MS Tags: Avonex, Bayhill Therapeutics, Betaseron, Children, Copaxone, Epstein-Barr Virus, MRI, MS, multiple sclerosis, pain, pedatric MS, Rebif, relapsin remitting multiple sclerosis, Research, Symptoms
Posted on March 29th, 2009
I would like to explain to you why I haven’t posted very many articles on my blog for the past few months.
I had a relapse in October 2008 and just could not seem to get my sluggish brain to do any research with any amount of understanding. Then came Christmas and all the hubbub over that. Our family has decided to make our read more »
Categories: Main Page Tags: blood clot, Emergency, Medicare, pain, white blood count
Posted on March 28th, 2009
Was your MRI of your brain or you spine as well? Many MRI’s as done of only the brain where there may not be lesions. An MRI done of both the brain and the spine is much more definitive of MS. read more »
Categories: Reader Comments
Posted on March 22nd, 2009
Visual problems are a common, often disabling symptom in MS and according to the National Multiple Sclerosis Society can affect over 40% of patients. The Impact of Visual Impairment Scale consists of 5 items that assess the extent to which various activities dependent upon vision are affected read more »
Categories: Quality of Life, Research Tags: MS, multiple sclerosis, Opexa, Quality of Life, Visual Impairment Scale, visual problems in MS
Posted on March 21st, 2009
Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neuro-degeneration that occurs in persons with multiple sclerosis, researchers have shown read more »
Categories: Research Tags: autoimmune disease, Epstein-Barr Virus, gadolinium-enhancing, gray matter atrophy, lesion, MS, multiple sclerosis, neurology